跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Spasmoline - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Spasmoline
Approved
STANDARD
Spasmoline
Scheele lab phils., Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
26ed3c448bfb947c
Company
Scheele lab phils., Inc
Type
Standard
Approval Details
Approval Id
26ed3c448bfb947c
Drug Approval Philippines Name
Spasmoline
Product Name
Spasmoline
Registration Number
DRP-3670
Brand Name
Spasmoline
Generic Name
DICYCLOVERINE HYDROCHLORIDE
Dosage Form
Syrup
Dosage Strength
10 mg/ 5mL
Manufacturer
Scheele lab phils., Inc
Issuance Date
29 March 2022
Expiry Date
15 March 2027
Pharmacologic Category
Synthetic anticholinergic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
26ed3c448bfb947c
Type
Standard
Back to Philippines FDA Approvals